Search
for

    Sort by

    Research 451–480 of 1000+

    1. Clinical Presentations and Comorbidities of Pediatric Alopecia Areata Pediatric Dermatology · 2025 · 4 citations
    2. Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient Internal Medicine · 2018 · 3 citations
    3. Onychomadesis: A rare adverse effect in early-period valproic acid therapy Türk pediatri arşivi : İstanbul çocuk kliniği dergisi · 2015 · 2 citations
    4. Cronkhite–Canada Syndrome With Multiple Mesenteric Lymphadenopathy: A Case Report JGH Open · 2025
    5. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2 Frontiers in immunology · 2019 · 98 citations
    6. Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions Pharmaceutics · 2021 · 29 citations
    7. Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis American journal of human genetics · 2019 · 53 citations
    8. Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review Dermatologic therapy · 2020 · 101 citations
    9. Plasma Dermatology: Skin Therapy Using Cold Atmospheric Plasma Frontiers in Oncology · 2022 · 46 citations
    10. Cure of alopecia areata after eradication of Helicobacter pylori: a new association? PubMed · 2011 · 26 citations
    11. Formulation-by-Design of Efinaconazole Spanlastic Nanovesicles for Transungual Delivery Using Statistical Risk Management and Multivariate Analytical Techniques Pharmaceutics · 2022 · 25 citations
    12. Poster Presentations Australasian Journal of Dermatology · 2021 · 25 citations
    13. Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model Veterinary Dermatology · 2009 · 23 citations
    14. Comprehensive treatment of Cronkhite-Canada syndrome: A case report and literature review Medicine · 2023 · 9 citations
    15. Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19 Skin health and disease · 2022 · 7 citations
    16. Cases Report the Cronkhite-Canada Syndrome Medicine · 2015 · 6 citations
    17. Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy MOJ bioequivalence & bioavailability · 2017 · 1 citations
    18. Alopecia areata: current concepts Wiener klinische Wochenschrift · 2026
    19. Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies Biomedicines · 2025
    20. Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases Frontiers in Medicine · 2025
    21. POS1510-HPR NUTRITIONAL STATUS AND DIETARY INTAKE ASSESSMENT IN PREGNANT WOMEN WITH RHEUMATIC DISEASES Annals of the Rheumatic Diseases · 2025
    22. Simultaneous HBV Reactivation and Hair Discoloration Under Secukinumab Treatment. PubMed · 2025
    23. Skin Disorders in Transgender Patients 2023
    24. Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study Dermatology practical & conceptual · 2022
    25. Role of <i>foxn1</i> in <i>Xenopus laevis</i> thymopoiesis. 2022
    26. Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape Wound practice & research · 2022
    27. Systemic lupus Erythematous as an Unusual Cause of Intussusception in Sudanese Woman: Case report Authorea (Authorea) · 2021
    28. Viva questions from the IJDVL Indian Journal of Dermatology, Venereology and Leprology · 2015
    29. The mouse keratin 6 isoforms are differentially expressed in the hair follicle, footpad, tongue and activated epidermis Differentiation · 1999 · 75 citations
    30. Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice Journal of Clinical Investigation · 2004 · 64 citations